Lung Cancer Biomarkers and Screening

Study acronym: NYULCBC
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 10850 to 3606v44
  2. Enrollment target: 9350 to 10850v43
  3. Enrollment target: 6860 to 9350v42
  4. Re-verified, no change to tracked fieldsv41
  5. Site contact updatedv40
Show 38 earlier versionsHide 38 earlier versions
  1. 2 versions Re-verified since Apr 19, 2021, no change to tracked fieldsv38-v39
  2. Primary and study completion dates: May 2020 to May 2030v37
  3. Primary and study completion dates: May 2019 to May 2020v36
  4. Re-verified, no change to tracked fieldsv35
  5. Primary and study completion dates: Sep 2018 to May 2019v34
  6. Primary completion date: Sep 2017 to Sep 2018v33
  7. Primary completion date: Sep 2016 to Sep 2017
    • Study completion date: Sep 2017 to Sep 2018
    v32
  8. Study completion date: Sep 2017v31
  9. Primary completion date: Jul 2015 to Sep 2016v30
  10. 3 versions Re-verified since May 20, 2013, no change to tracked fieldsv27-v29
  11. Phase: Not applicable to Not specifiedv26 Show 9 more changesShow less
    • Enrollment target: 1450 to 6860
    • Primary completion date: Feb 2010 to Jul 2015
    • Interventions: biopsy (Procedure), bronchoscopy (Procedure), laboratory biomarker analysis (Other), screening questionnaire administration (Other) to not stated
    • Secondary endpoints: details revised at 1 of 1 entry
    • Publications: 1 to 3
    • Study arms: 0 to 2
    • Study description shortened, about 1 word
    • Collaborators shortened, about 4 words
    • Study title shortened, about 2 words
  12. Re-verified, no change to tracked fieldsv25
  13. Interventions: biopsy (Procedure), bronchoscopy (Procedure), laboratory biomarker analysis (Procedure), screening questionnaire administration (Procedure) to biopsy (Procedure), bronchoscopy (Procedure), laboratory biomarker analysis (Other), screening questionnaire administration (Other)v24
  14. 2 versions Re-verified since Jul 23, 2008, no change to tracked fieldsv22-v23
  15. Phase: Not specified to Not applicablev21
  16. Primary completion date: Feb 2010
    • Start date: Oct 2005 to May 2000
    v20
  17. Start date: Oct 2005v19
  18. Interventions: biopsy (Procedure), bronchoscopy (Procedure), laboratory biomarker analysis (Procedure), screening and diagnostic assessment (Procedure)… to biopsy (Procedure), bronchoscopy (Procedure), laboratory biomarker analysis (Procedure), screening questionnaire administration (Procedure)v18
  19. Publications: details revised at 1 of 1 entryv17
  20. Interventions: Intervention/procedure (Procedure), behavioral, psychological or informational intervention (Procedure), biomarker analysis (Procedure)… to biopsy (Procedure), bronchoscopy (Procedure), laboratory biomarker analysis (Procedure), screening and diagnostic assessment (Procedure)…v16
  21. Interventions: Intervention/procedure (Procedure), behavioral, psychological or informational intervention (Procedure), biological markers (Procedure)… to Intervention/procedure (Procedure), behavioral, psychological or informational intervention (Procedure), biomarker analysis (Procedure)…v15
  22. Interventions: biological markers (Procedure), biopsies (Procedure), bronchoscopy (Procedure), screening and diagnostic assessment (Procedure), screening… to Intervention/procedure (Procedure), behavioral, psychological or informational intervention (Procedure), biological markers (Procedure)…v14
  23. Study description shortened, about 19 wordsv13
  24. Re-verified, no change to tracked fieldsv12
  25. Study Status, Eligibilityv11
  26. 3 versions Re-verified since Jan 5, 2007, no change to tracked fieldsv8-v10
  27. Enrollment target: 1450
    • Eligibility criteria expanded, about 19 words
    • Study description expanded, about 9 words
    v7
  28. 4 versions Re-verified since May 23, 2006, no change to tracked fieldsv3-v6
  29. Interventions: biological markers (Procedure), bronchoscopy (Procedure), screening and diagnostic assessment (Procedure), screening intervention… to biological markers (Procedure), biopsies (Procedure), bronchoscopy (Procedure), screening and diagnostic assessment (Procedure), screening…
    • Study description expanded, about 8 words
    • Eligibility criteria shortened, about 1 word
    • Study title shortened, about 4 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
Trial Details
NCT Number NCT00301119
Lead Sponsor NYU Langone Health
Conditions
(from sponsor)		 Lung Cancer
Related terms Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma
Enrollment 3,606 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov